Our CEO Deana Mohr had the great opportunity to present MUVONs vision and innovative regenerative cell therapy in an interview for BioInnovation Spotlight @ LifeScience ORG! Listen to the interview here: https://bioinnovation.captivate.fm/episode/13-deana-mohr or on Spotify: https://open.spotify.com/episode/3fjHsK0ZfIWHS1rawOj2Fd?si=aoZ_SZ0bSseTtnWF5jr2Sg

Informative article published in BioInsights , written by our CSO Jenny Prange and our innovation manager Beatrix Rauch Schmid . This viewpoint gives a short summary about what needs to be considered to transfer an autologous celltherapy from bench to bedside and what automation challenges could arise during future development. Read the full article here .

MUVON Therapeutics was selected as one of twelve finalists for 2021's IFAS Innovation Challenge and placed second in the final pitching round. With this MUVON has won an exhibition booth at the IFAS Expo taking place in October 2022 in Zurich. The IFAS Innovation Challenge was set up by Cosanum AG (a leading, Swiss healthcare logistics company) to foster innovation in the Swiss healthcare system. Read the full announcement on LinkedIn . Image Source: Cosanum AG